ARTICLE | Top Story
Centocor returns antibody to Crucell
December 24, 2002 8:00 AM UTC
Centocor (Malvern, Penn.) returned to Crucell (Euronext:CRXL; CRXL) all rights to the CD46 target and anti-CD46 antibody, which it had licensed in 2001. Centocor, a Johnson & Johnson (JNJ) subsidiary,...